{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,26]],"date-time":"2025-11-26T05:07:25Z","timestamp":1764133645282,"version":"3.44.0"},"reference-count":21,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","gynecologiconcology-online.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2023,6]]},"DOI":"10.1016\/j.ygyno.2023.03.023","type":"journal-article","created":{"date-parts":[[2023,4,8]],"date-time":"2023-04-08T11:20:54Z","timestamp":1680952854000},"page":"15-21","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Glassy cell carcinoma of the cervix: Findings from a combined National Cancer Database analysis and single institution review of treatment patterns and outcomes"],"prefix":"10.1016","volume":"173","author":[{"given":"Monica D.","family":"Levine","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David A.","family":"Barrington","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Caitlin E.","family":"Meade","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sydney M.","family":"Lammers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eric M.","family":"McLaughlin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adrian A.","family":"Suarez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Floor J.","family":"Backes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Larry J.","family":"Copeland","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David M.","family":"O'Malley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Casey M.","family":"Cosgrove","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David E.","family":"Cohn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christa I.","family":"Nagel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ashley S.","family":"Felix","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kristin L.","family":"Bixel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"45","key":"10.1016\/j.ygyno.2023.03.023_bb0005","doi-asserted-by":"crossref","first-page":"74152","DOI":"10.18632\/oncotarget.12361","article-title":"Cytomorphological characteristics of glassy cell carcinoma of the uterine cervix: histopathological correlation and human papillomavirus genotyping","volume":"7","author":"Jung","year":"2016","journal-title":"Oncotarget"},{"year":"2021","series-title":"NCCN Clinical Practice Guidelines and Version 1.2022, \u201cNCCN Clinical Practice Guidelines in Oncology: Cervical Cancer\u201d","key":"10.1016\/j.ygyno.2023.03.023_bb0010"},{"issue":"5","key":"10.1016\/j.ygyno.2023.03.023_bb0015","doi-asserted-by":"crossref","first-page":"2238","DOI":"10.1002\/1097-0142(197605)37:5<2238::AID-CNCR2820370513>3.0.CO;2-D","article-title":"Glassy cell carcinoma of the cervix","volume":"37","author":"Littman","year":"1976","journal-title":"Cancer"},{"issue":"6 Pt 1","key":"10.1016\/j.ygyno.2023.03.023_bb0020","first-page":"837","article-title":"Glassy cell carcinoma of the cervix redefined","volume":"71","author":"Tamimi","year":"1988","journal-title":"Obstet. Gynecol."},{"issue":"3","key":"10.1016\/j.ygyno.2023.03.023_bb0025","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/0090-8258(92)90052-K","article-title":"Glassy cell carcinoma of the cervix: a bimodal treatment strategy","volume":"44","author":"Lotocki","year":"1992","journal-title":"Gynecol. Oncol."},{"issue":"3","key":"10.1016\/j.ygyno.2023.03.023_bb0030","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1111\/j.1447-0756.2008.00968.x","article-title":"Multimodal treatment for glassy cell carcinoma of the uterine cervix","volume":"35","author":"Nasu","year":"2009","journal-title":"J. Obstet. Gynaecol. Res."},{"issue":"48","key":"10.1016\/j.ygyno.2023.03.023_bb0035","doi-asserted-by":"crossref","first-page":"78448","DOI":"10.18632\/oncotarget.12905","article-title":"Clinical outcomes of advanced-stage glassy cell carcinoma of the uterine cervix: a need for reappraisal","volume":"7","author":"Yoon","year":"2016","journal-title":"Oncotarget"},{"issue":"2","key":"10.1016\/j.ygyno.2023.03.023_bb0040","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.ygyno.2014.01.048","article-title":"Glassy cell carcinoma of the cervix: a systematic review and meta-analysis","volume":"133","author":"Guitarte","year":"2014","journal-title":"Gynecol. Oncol."},{"issue":"1","key":"10.1016\/j.ygyno.2023.03.023_bb0045","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1002\/ijgo.12749","article-title":"Revised FIGO staging for carcinoma of the cervix uteri","volume":"145","author":"Bhatla","year":"2019","journal-title":"Int. J. Gynaecol. Obstet."},{"issue":"9","key":"10.1016\/j.ygyno.2023.03.023_bb0050","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1001\/jamasurg.2018.0492","article-title":"Practical guide to surgical data sets: National Cancer Database (NCDB)","volume":"153","author":"Merkow","year":"2018","journal-title":"JAMA Surg"},{"issue":"3","key":"10.1016\/j.ygyno.2023.03.023_bb0055","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1245\/s10434-007-9747-3","article-title":"The National Cancer Data Base: a powerful initiative to improve cancer care in the United States","volume":"15","author":"Bilimoria","year":"2008","journal-title":"Ann. Surg. Oncol."},{"issue":"2","key":"10.1016\/j.ygyno.2023.03.023_bb0060","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1006\/gyno.1999.5387","article-title":"A randomized trial of pelvic radiation therapy versus no further therapy in selected patients with stage IB carcinoma of the cervix after radical hysterectomy and pelvic lymphadenectomy: a Gynecologic Oncology Group Study","volume":"73","author":"Sedlis","year":"1999","journal-title":"Gynecol. Oncol."},{"issue":"1","key":"10.1016\/j.ygyno.2023.03.023_bb0065","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.ygyno.2018.10.026","article-title":"Validation of the 2018 FIGO cervical cancer staging system","volume":"152","author":"Matsuo","year":"2019","journal-title":"Gynecol. Oncol."},{"issue":"17","key":"10.1016\/j.ygyno.2023.03.023_bb0070","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1200\/JCO.18.01265","article-title":"Efficacy and safety of pembrolizumab in previously treated advanced cervical cancer: results from the phase II KEYNOTE-158 study","volume":"37","author":"Chung","year":"2019","journal-title":"J. Clin. Oncol."},{"issue":"20","key":"10.1016\/j.ygyno.2023.03.023_bb0075","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.1056\/NEJMoa2112435","article-title":"Pembrolizumab for persistent, recurrent, or metastatic cervical cancer","volume":"385","author":"Colombo","year":"2021","journal-title":"N. Engl. J. Med."},{"issue":"5","key":"10.1016\/j.ygyno.2023.03.023_bb0080","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/S1470-2045(21)00056-5","article-title":"Efficacy and safety of tisotumab vedotin in previously treated recurrent or metastatic cervical cancer (innovaTV 204\/GOG-3023\/ENGOT-cx6): a multicentre, open-label, single-arm, phase 2 study","volume":"22","author":"Coleman","year":"2021","journal-title":"Lancet Oncol"},{"issue":"9590","key":"10.1016\/j.ygyno.2023.03.023_bb0085","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1016\/S0140-6736(07)61416-0","article-title":"Human papillomavirus and cervical cancer","volume":"370","author":"Schiffman","year":"2007","journal-title":"Lancet"},{"issue":"7","key":"10.1016\/j.ygyno.2023.03.023_bb0090","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1093\/aje\/kwt077","article-title":"Clinical progression of high-grade cervical intraepithelial neoplasia: estimating the time to preclinical cervical cancer from doubly censored national registry data","volume":"178","author":"Vink","year":"2013","journal-title":"Am. J. Epidemiol."},{"key":"10.1016\/j.ygyno.2023.03.023_bb0095","first-page":"1","article-title":"Survival disparities by hospital volume among American women with gynecologic cancers","volume":"1","author":"Seagle","year":"2017","journal-title":"JCO Clin Cancer Inform"},{"issue":"2","key":"10.1016\/j.ygyno.2023.03.023_bb0100","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1006\/gyno.2001.6523","article-title":"Glassy cell carcinoma of the cervix revisited","volume":"85","author":"Gray","year":"2002","journal-title":"Gynecol. Oncol."},{"issue":"3","key":"10.1016\/j.ygyno.2023.03.023_bb0105","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1016\/j.ygyno.2021.06.017","article-title":"Beyond Sedlis-a novel histology-specific nomogram for predicting cervical cancer recurrence risk: an NRG\/GOG ancillary analysis","volume":"162","author":"Levinson","year":"2021","journal-title":"Gynecol. Oncol."}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825823001701?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825823001701?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T04:03:53Z","timestamp":1758773033000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090825823001701"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6]]},"references-count":21,"alternative-id":["S0090825823001701"],"URL":"https:\/\/doi.org\/10.1016\/j.ygyno.2023.03.023","relation":{},"ISSN":["0090-8258"],"issn-type":[{"type":"print","value":"0090-8258"}],"subject":[],"published":{"date-parts":[[2023,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Glassy cell carcinoma of the cervix: Findings from a combined National Cancer Database analysis and single institution review of treatment patterns and outcomes","name":"articletitle","label":"Article Title"},{"value":"Gynecologic Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ygyno.2023.03.023","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}